Global and United States Point-of-Care Infectious Disease Diagnostics/Testing Market 2020 by Company, Type and Application, Forecast to 2025

Table of Contents

1 Point-of-Care Infectious Disease Diagnostics/Testing Market Overview

• 1.1 Product Overview and Scope of Point-of-Care Infectious Disease Diagnostics/Testing
• 1.2 Classification of Point-of-Care Infectious Disease Diagnostics/Testing by Type
  • 1.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type in 2019
  • 1.2.3 HIV POC
  • 1.2.4 Clostridium difficile POC
  • 1.2.5 HBV POC
  • 1.2.6 Pneumonia or Streptococcus associated infections
  • 1.2.7 Respiratory syncytial virus (RSV) POC
  • 1.2.8 HPV POC
  • 1.2.9 Influenza/Flu POC
  • 1.2.10 Other Infectious Disease POC
• 1.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Market by Application
  • 1.3.1 Overview: Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Home
  • 1.3.5 Assisted Living Healthcare Facilities
  • 1.3.6 Laboratories
  • 1.3.7 Others
• 1.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Market by Regions
  • 1.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Point-of-Care Infectious Disease Diagnostics/Testing (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Abbott
  • 2.1.1 Abbott Details
  • 2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Abbott SWOT Analysis
  • 2.1.4 Abbott Product and Services
  • 2.1.5 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Cardinal Health
  • 2.2.1 Cardinal Health Details
  • 2.2.2 Cardinal Health Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Cardinal Health SWOT Analysis
  • 2.2.4 Cardinal Health Product and Services
  • 2.2.5 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Siemens Healthineers
  • 2.3.1 Siemens Healthineers Details
  • 2.3.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Siemens Healthineers SWOT Analysis
  • 2.3.4 Siemens Healthineers Product and Services
  • 2.3.5 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Thermo Fisher Scientific Inc
  • 2.4.1 Thermo Fisher Scientific Inc Details
  • 2.4.2 Thermo Fisher Scientific Inc Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Thermo Fisher Scientific Inc SWOT Analysis
  • 2.4.4 Thermo Fisher Scientific Inc Product and Services
  • 2.4.5 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Trinity Biotech
  • 2.5.1 Trinity Biotech Details
  • 2.5.2 Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Trinity Biotech SWOT Analysis
  • 2.5.4 Trinity Biotech Product and Services
  • 2.5.5 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 F. Hoffmann-La Roche Ltd
  • 2.6.1 F. Hoffmann-La Roche Ltd Details
  • 2.6.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 F. Hoffmann-La Roche Ltd SWOT Analysis
  • 2.6.4 F. Hoffmann-La Roche Ltd Product and Services
  • 2.6.5 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Bio-Rad Labs Inc.
  • 2.7.1 Bio-Rad Labs Inc. Details
  • 2.7.2 Bio-Rad Labs Inc. Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Bio-Rad Labs Inc. SWOT Analysis
  • 2.7.4 Bio-Rad Labs Inc. Product and Services
  • 2.7.5 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Chembio Diagnostics Inc.
  • 2.8.1 Chembio Diagnostics Inc. Details
  • 2.8.2 Chembio Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Chembio Diagnostics Inc. SWOT Analysis
  • 2.8.4 Chembio Diagnostics Inc. Product and Services
  • 2.8.5 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 BD & Company
  • 2.9.1 BD & Company Details
  • 2.9.2 BD & Company Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 BD & Company SWOT Analysis
  • 2.9.4 BD & Company Product and Services
  • 2.9.5 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Quest Diagnostics Inc.
  • 2.10.1 Quest Diagnostics Inc. Details
  • 2.10.2 Quest Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Quest Diagnostics Inc. SWOT Analysis
  • 2.10.4 Quest Diagnostics Inc. Product and Services
  • 2.10.5 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 OJ-Bio Ltd.
  • 2.11.1 OJ-Bio Ltd. Details
  • 2.11.2 OJ-Bio Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 OJ-Bio Ltd. SWOT Analysis
  • 2.11.4 OJ-Bio Ltd. Product and Services
  • 2.11.5 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 bioMérieux SA
  • 2.12.1 bioMérieux SA Details
  • 2.12.2 bioMérieux SA Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 bioMérieux SA SWOT Analysis
  • 2.12.4 bioMérieux SA Product and Services
  • 2.12.5 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 Ortho-Clinical Diagnostics
  • 2.13.1 Ortho-Clinical Diagnostics Details
  • 2.13.2 Ortho-Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 Ortho-Clinical Diagnostics SWOT Analysis
  • 2.13.4 Ortho-Clinical Diagnostics Product and Services
  • 2.13.5 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.14 Trivitron Healthcare
  • 2.14.1 Trivitron Healthcare Details
  • 2.14.2 Trivitron Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.14.3 Trivitron Healthcare SWOT Analysis
  • 2.14.4 Trivitron Healthcare Product and Services
  • 2.14.5 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.15 Sight Diagnostics Ltd.
  • 2.15.1 Sight Diagnostics Ltd. Details
  • 2.15.2 Sight Diagnostics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.15.3 Sight Diagnostics Ltd. SWOT Analysis
  • 2.15.4 Sight Diagnostics Ltd. Product and Services
  • 2.15.5 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.16 Gene POC
  • 2.16.1 Gene POC Details
  • 2.16.2 Gene POC Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.16.3 Gene POC SWOT Analysis
  • 2.16.4 Gene POC Product and Services
  • 2.16.5 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Point-of-Care Infectious Disease Diagnostics/Testing Players Market Share
  • 3.2.2 Top 10 Point-of-Care Infectious Disease Diagnostics/Testing Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Regions
• 4.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 4.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 4.5 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

5 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries

• 5.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
• 5.2 USA Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 5.3 Canada Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

6 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries

• 6.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
• 6.2 Germany Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 6.3 UK Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 6.4 France Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 6.5 Russia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 6.6 Italy Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries

• 7.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
• 7.2 China Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 7.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 7.4 Korea Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 7.5 India Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

8 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries

• 8.1 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
• 8.2 Brazil Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Point-of-Care Infectious Disease Diagnostics/Testing by Countries

• 9.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 9.3 UAE Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Type (2015-2020)
• 10.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast by Type (2019-2024)
• 10.3 HIV POC Revenue Growth Rate (2015-2025)
• 10.4 Clostridium difficile POC Revenue Growth Rate (2015-2025)
• 10.5 HBV POC Revenue Growth Rate (2015-2025)
• 10.6 Pneumonia or Streptococcus associated infections Revenue Growth Rate (2015-2025)
• 10.7 Respiratory syncytial virus (RSV) POC Revenue Growth Rate (2015-2025)
• 10.8 HPV POC Revenue Growth Rate (2015-2025)
• 10.9 Influenza/Flu POC Revenue Growth Rate (2015-2025)
• 10.10 Other Infectious Disease POC Revenue Growth Rate (2015-2025)

11 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Segment by Application

• 11.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Application (2015-2020)
• 11.2 Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2015-2020)
• 11.4 Clinics Revenue Growth (2015-2020)
• 11.5 Home Revenue Growth (2015-2020)
• 11.6 Assisted Living Healthcare Facilities Revenue Growth (2015-2020)
• 11.7 Laboratories Revenue Growth (2015-2020)
• 11.8 Others Revenue Growth (2015-2020)

12 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast (2021-2025)

• 12.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast (2021-2025)
• 12.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast by Regions (2021-2025)
• 12.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
• 12.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
• 12.6 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer